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The first milestones have been reached 
towards the integration of multiple types of 
real-time data into a mobile decision support 
system that uses artificial intelligence and 
predictive modelling to adapt its advice 
according to the needs of the individual. 
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The first prototype system has been 
designed, using feedback from patients and 
clinicians, and tested using the UVA/Padova 
Type 1 diabetes simulator. Three subsequent 
phases of clinical tests are planned. The first 
two will study safety, feasibility and usability 
in situ; the last is a randomised control trial, 
in 2018.  
 
PEPPER (Patient Empowerment through 
Predictive PERsonalised decision support) is 
an EU-funded research project to develop a 
personalised clinical decision support 
system for Type 1 diabetes self-
management.  The tool provides insulin 
bolus dose advice and carbohydrate 
recommendations, tailored to the needs of 
individuals. The former is determined by 
Case-Based Reasoning (CBR, Fig. 1), an 
artificial intelligence technique that adapts 
to new situations according to past 
experience. The latter uses a predictive 
computer model (Fig. 2) that also promotes 
safety by providing glucose alarms, low-
glucose insulin suspension and fault 
detection.  
Method 
The user-centred design methodology aims 
to ensure that the tool meets patient needs 
and improves clinical outcomes. A dual 
architecture (Fig.3) accommodates insulin 
dosing either by insulin pen or via the 
Cellnovo patch-pump (Fig. 4). Data are 
gathered wirelessly in real-time from multiple 
sources including a continuous glucose 
monitor, capillary glucose monitor and 
physical activity monitor. The design ethos is 
to offer maximum benefit for minimum effort, 
so additional manual data entry is strictly 
limited.  
 
Fig.3 The PEPPER system architecture 
Fig. 1 CBR cycle, adapted to the problem of calculating 
an insulin dose 
Fig.2 Example of the dynamic constraints using retrospective 
clinical data. Upper graph: glucose levels represented by an 
interval envelope. Lower graph: Vertical black bars represent 
the actual boluses; the envelope represents the constraint.  
Fig.4 The Cellnovo system 
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